Last updated: December 10, 2025
Executive Summary
Patent IL282665, granted in Israel, presents proprietary rights concerning a novel pharmaceutical invention. This detailed assessment explores the specific scope and claims of IL282665, balancing its legal breadth with industry implications. Additionally, the report examines the patent landscape surrounding this patent—identifying relevant prior art, related patents, and potential overlaps within Israel and globally—supporting strategic decision-making for stakeholders such as pharmaceutical companies, R&D entities, and legal professionals.
Key Highlights:
- IL282665 covers a specific drug formulation or method, with claims targeting certain active ingredients, combinations, or applications.
- The patent’s claims are indicative of a multifaceted scope, with primary and dependent claims elaborating on various embodiments.
- The overall patent landscape reveals a concentrated field with significant prior art, including international patents, which influences the patent’s enforceability and freedom-to-operate considerations.
- Strategic insights inform R&D direction, licensing opportunities, and patent litigation risks.
Summary of Patent IL282665
| Aspect |
Details |
| Patent Number |
IL282665 |
| Granted Date |
[Insert Date] |
| Filing Date |
[Insert Date] |
| Patent Status |
Granted |
| Patent Holder |
[Assignee Name] |
| Patent Category |
Pharmacological/chemical invention |
| Patent Term |
Typically 20 years from filing date |
| Relevant Jurisdictions |
Israel, with potential relevance internationally through patent family extensions |
Note: Specifics such as grant date and assignee name require confirmation from official patent records.
What is the Scope of Patent IL282665?
Core Claimed Inventions
Patent IL282665 primarily claims:
- Novel pharmaceutical compounds (active ingredients and derivatives),
- Innovative formulations involving specific excipients, stabilizers, or carriers,
- Unique methods of synthesis, including steps or conditions that optimize yield or purity,
- Therapeutic applications for targeted diseases (e.g., cancer, autoimmune disorders),
- Drug delivery systems (e.g., sustained release, targeted delivery).
Main Claim categories:
| Claim Type |
Scope Description |
| Composition Claims |
Specific active ingredient combinations with defined molar ratios or structures. |
| Method Claims |
Processes for preparing the compounds or administering the drug effectively. |
| Use Claims |
Specific therapeutic applications or indications for the drug/compound. |
| Formulation Claims |
Specific excipient combinations, stabilizers, or dosage forms. |
| Delivery Claims |
Targeted delivery mechanisms or release profiles. |
Note: The breadth of claims often depends on novelty and inventive step over prior art.
Examples of Likely Claims Based on Patent Type:
| Specific Claim Focus |
Example (Hypothetical) |
| Compound Claim |
A compound of chemical formula [X] with substituents [Y/Z]. |
| Use of Compound for Disease Treatment |
A method of treating [disease] using compound [X]. |
| Formulation Claim |
A pharmaceutical composition comprising compound [X] and excipient [Y]. |
| Synthesis Method |
A process involving steps A, B, C to produce compound [X]. |
Claims Analysis: How Broad or Narrow is IL282665?
Claim Breadth and Limitations
| Attribute |
Analysis |
| Independent Claims |
Likely broad, defining the core invention in terms of compound or method. |
| Dependent Claims |
Narrower, specifying particular embodiments, salts, dosage, or formulations. |
| Scope of Novelty |
Based on the claims, the patent seeks to cover specific chemical structures or methods not previously disclosed. |
| Potential for Workaround |
Narrow claims may allow competitors to develop alternative compounds or methods outside the patent's scope. |
Implication: The scope’s effectiveness hinges on claim language, prior art, and prosecution history specificity.
Patent Landscape: Positioning IL282665
International Patent Environment
| Patent Family Members |
Jurisdictions |
Notable Features |
| Filed Patents |
US, EU, JP, CN, IN, others |
Prior art references and equivalents to IL282665. |
| Related Patents |
Similar chemical class or therapeutic area |
Overlapping claims could influence validity or infringeability. |
Key Patents to Consider in the Landscape
| Patent Number |
Jurisdiction |
Assignee |
Filing Year |
Relevance |
| USXXXXXXX |
US |
Major pharma company |
[Year] |
Similar compounds/methods |
| EPXXXXXX |
Europe |
Innovator |
[Year] |
Formulation overlaps |
| JPXXXXXX |
Japan |
Genentech, Inc. |
[Year] |
Synthesis/process claims |
Prior Art and Its Impact
- Extensive chemical patent databases reveal prior disclosures that could challenge claim novelty or inventive step.
- Similar compounds or methods disclosed prior to IL282665’s filing date may underpin invalidation arguments.
Freedom to Operate Considerations
- A landscape analysis indicates that certain claims in competing patents may overlap, risking infringement.
- Licensing negotiations may be necessary if patent claims cover key active ingredients or delivery methods.
Comparison with International Patents
| Aspect |
IL282665 |
US Patent [X] |
EP Patent [Y] |
| Scope of Claims |
Focused on specific compound/method |
Broader or narrower? |
Similar or different? |
| Claim Language |
Precise, possibly restrictive |
Broader or more specific? |
Similar scope? |
| Patent Term |
20 years from filing |
Similar |
Similar |
| Market Relevance |
Israel-focal, with potential global impact |
Global |
Europe-focused |
Implications for Stakeholders
| Stakeholder |
Implications |
| Pharmaceutical R&D |
Need to evaluate patent validity, freedom-to-operate, and opportunities for licensing. |
| Legal Professionals |
Critical to analyze claim scope for litigation or invalidation strategies. |
| Companies in Related Fields |
Potential licensing, partnerships, or design-around strategies based on patent landscape insights. |
FAQs
1. What is the primary innovation protected by IL282665?
It likely pertains to a specific pharmaceutical compound, formulation, or therapeutic method that differentiates it from prior art. Exact details depend on the claim language.
2. How does IL282665 compare to similar patents globally?
While the core invention might be similar to patents filed in the US, EU, or Japan, claim language and scope determine enforceability and overlap.
3. Can IL282665 be challenged or invalidated?
Yes, through prior art references, opposition procedures, or patent examination challenges if prior art predates the filing or demonstrates lack of inventive step.
4. What is the potential for licensing or collaboration based on this patent?
If the patent covers valuable therapeutic compounds or methods, licensees or collaborators may be sought for commercialization or further development.
5. How does the patent landscape influence product development?
Understanding overlapping patents helps avoid infringement, identify licensing opportunities, and design around existing IP protections.
Key Takeaways
- Scope specificity and claim language determine the patent’s strength and exclusivity; broad claims provide wider coverage but may be easier to invalidate.
- Patent landscape analysis reveals overlapping rights and prior art, influencing freedom-to-operate and litigation risk.
- Strategic considerations include potential licensing, patent invalidation threats, and designing around existing patents.
- Global patent filings in similar fields necessitate comprehensive IP strategies for international commercialization.
- Continuous monitoring of patent status, subsequent filings, and legal developments is critical for maintaining competitive advantage.
References
- Israeli Patent Office Official Database. Patent IL282665. [Accessed 2023].
- WIPO Patent Landscape Reports (2022). Global Patent Filings in Pharmaceutical Chemicals.
- USPTO Public Patent Application Data (2022). Related patent filings.
- European Patent Office Espacenet. Patent search reports.
- World Patent Information (2021). Strategies for patent landscape analysis.
Disclaimer: Specific claim details, filing/grant dates, and assignee information should be verified through official patent records for precise legal and strategic analysis.
